At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
OZEM Roundhill GLP-1 & Weight Loss ETF
Trading 08-31 14:20:57 EDT
32.81
-0.64
-1.90%
High33.06Low32.72Vol5.96K
Open33.06D1 Closing33.44Amplitude1.02%
Mkt Cap63.31MTradable Cap63.31MTotal Shares1.93M
T/O195.67KT/O Rate0.31%Tradable Shares1.93M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Sector Update: Healthcare Stocks Decline Monday Afternoon
MT Newswires Live  ·  44 minutes ago
Sector Update: Healthcare Stocks Decline Monday Afternoon
Moderately bullish activity in Eli Lilly with shares down 1.26%
TIPRANKS  ·  00:10
Moderately bullish activity in Eli Lilly with shares down 1.26%
Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market
Dow Jones  ·  00:02
Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market
Top Midday Stories: Stocks Fall, Oil Rises Amid Renewed Fighting in Middle East; Utility Shares Fall After California Wildfire Legislation
MT Newswires Live  ·  08-31 23:39
Top Midday Stories: Stocks Fall, Oil Rises Amid Renewed Fighting in Middle East; Utility Shares Fall After California Wildfire Legislation
Dow Jones Top Company Headlines at 11 am ET: GameStop Sees Higher Profit as eBay Investment Offsets Lower Sales | SLB ...
Dow Jones  ·  08-31 23:00
Dow Jones Top Company Headlines at 11 am ET: GameStop Sees Higher Profit as eBay Investment Offsets Lower Sales | SLB ...
Novo Nordisk Advances DKK 15 Billion Share Buyback Programme Through Late August 2026
TIPRANKS  ·  08-31 21:50
Novo Nordisk Advances DKK 15 Billion Share Buyback Programme Through Late August 2026
Lilly is Bigger than Ever. Why Its Latest $2.9 Billion Immunology Deal Makes Sense.
Dow Jones  ·  08-31 20:38
Lilly is Bigger than Ever. Why Its Latest $2.9 Billion Immunology Deal Makes Sense.
Eli Lilly's Psoriasis Drug Trial Shows Sustained Positive Results
Dow Jones  ·  08-31 19:52
Eli Lilly's Psoriasis Drug Trial Shows Sustained Positive Results
Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What it Means for the Stock.
Dow Jones  ·  08-31 19:23
Lilly to Buy This Autoimmune Drugmaker for $2.9 Billion in Cash. What it Means for the Stock.
Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA
TIPRANKS  ·  08-31 19:15
Eli Lilly announces 52-week results from TOGETHER-PsO, TOGETHER-PsA
Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials
THOMSON REUTERS  ·  08-31 19:00
Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials
New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Showed Improved and Durable Efficacy at One Year in Adults with Psoriatic Disease and Obesity
THOMSON REUTERS  ·  08-31 19:00
New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Showed Improved and Durable Efficacy at One Year in Adults with Psoriatic Disease and Obesity
Eli Lilly - Taltz and Zepbound Maintain or Improve Disease Activity at Week 52 Versus Taltz Alone
THOMSON REUTERS  ·  08-31 19:00
Eli Lilly - Taltz and Zepbound Maintain or Improve Disease Activity at Week 52 Versus Taltz Alone
Eli Lilly: Adverse Events in Participants Treated with Taltz and Zepbound Together were Generally Mild to Moderate
THOMSON REUTERS  ·  08-31 19:00
Eli Lilly: Adverse Events in Participants Treated with Taltz and Zepbound Together were Generally Mild to Moderate
Lilly to Acquire Merida Biosciences in Deal Worth up to USD 2.88 Billion
Reuters  ·  08-31 18:45
Lilly to Acquire Merida Biosciences in Deal Worth up to USD 2.88 Billion
Eli Lilly: Under Terms of Agreement, Lilly Will Acquire Merida and Pay up to $2.875 Bln in Cash
THOMSON REUTERS  ·  08-31 18:45
Eli Lilly: Under Terms of Agreement, Lilly Will Acquire Merida and Pay up to $2.875 Bln in Cash
Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases
THOMSON REUTERS  ·  08-31 18:45
Lilly to Acquire Merida Biosciences to Advance Treatments for Serious Autoimmune and Allergic Diseases
Eli Lilly - Deal Expected to Close in Q4 2026 Subject to Regulatory Approvals
THOMSON REUTERS  ·  08-31 18:45
Eli Lilly - Deal Expected to Close in Q4 2026 Subject to Regulatory Approvals
Pfizer Pivots: New Trials Target Obesity, Cancer, Autoimmune
TIPRANKS  ·  08-29 23:03
Pfizer Pivots: New Trials Target Obesity, Cancer, Autoimmune
Pharma Industry Stares Down Biggest Patent Cliff in Decades
Dow Jones  ·  08-29 09:00
Pharma Industry Stares Down Biggest Patent Cliff in Decades

Introduction

Company Name.
Roundhill GLP-1 & Weight Loss ETF
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--